FOXO TECHNOLOGIES INC.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
FOXO$0.13+19.2%Stored close · as of Jul 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
FOXO technologies inc. and subsidiaries
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $207,453 | $68,268 |
| Accounts receivable, net | 2,468,346 | 2,270,957 |
| Inventory and supplies | 183,627 | 161,466 |
| Prepaid expenses | 97,691 | 291,011 |
| Other current assets | 155,363 | 89,564 |
| Total current assets | 3,112,480 | 2,881,266 |
| Property and equipment, net | 322,357 | 364,481 |
| Intangible assets, net | 9,770,969 | 9,015,556 |
| Goodwill | 27,823,444 | 25,463,948 |
| Right-of-use assets | 3,548,623 | 3,982,820 |
| Total assets | $44,577,873 | $41,708,071 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $6,966,211 | $6,677,281 |
| Accrued expenses | 11,902,383 | 11,994,783 |
| Notes payable | 2,151,838 | 7,279,724 |
| Related parties’ notes and loans payable | 4,902,392 | 2,671,924 |
| Other loans | 237,810 | 268,257 |
| Related parties’ payables and accrued expenses | 1,998,775 | 1,941,385 |
| Right-of-use lease obligations | 499,351 | 367,474 |
| Total current liabilities | 28,658,760 | 31,200,828 |
| Warrant liabilities | - | 41,246 |
| Contingent purchase price consideration | 500,000 | - |
| Right-of-use lease obligations, non-current | 3,174,549 | 3,667,553 |
| Medicare cost report settlement payables | 1,168,264 | 1,526,633 |
| Total liabilities | 33,501,573 | 36,436,260 |
| Commitments and contingencies (Note 18) | - | - |
| Stockholders’ equity (deficit) | ||
| Series A preferred stock, $0.0001 par value and $1,000 stated value per share; 50,000 shares authorized, 19,341 and 22,540 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 2 | 2 |
| Series B preferred stock, $0.0001 par value and $1,000 stated value per share; 7,500 shares authorized, 3,245 and 0 shares issued and outstanding as of December 31, 2025 and 2024, respectively | - | - |
| Series C preferred stock, $0.0001 par value and $1,000 stated value per share; 5,000 shares authorized, 304 and 120 shares issued and outstanding as of December 31, 2025 and 2024, respectively | - | - |
| Series D preferred stock, $0.0001 par value and $1,000 stated value per share; 10,000 shares authorized, 4,312 issued and outstanding as of December 31, 2025 and 2024 | 1 | 1 |
| Series E preferred stock, $0.0001 par value and $25 stated value per share; 4,000,000 shares authorized, 68,000 and 0 issued and outstanding as of December 31, 2025 and 2024, respectively | 7 | - |
| Class A common stock, $0.0001 par value, 2,500,000,000 shares authorized, 2,495,660,151 and 1,183,942 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 249,566 | 119 |
| Additional paid-in-capital | 235,540,145 | 195,864,697 |
| Accumulated deficit | (224,644,739) | (190,541,067) |
| Total FOXO’s stockholders’ equity | 11,144,982 | 5,323,752 |
| Noncontrolling interest | (68,682) | (51,941) |
| Total stockholders’ equity | 11,076,300 | 5,271,811 |
| Total liabilities and stockholders’ equity | $44,577,873 | $41,708,071 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.